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Introduction
Members of the Tumor Necrosis Factor (TNF) superfamily are type II membrane proteins, each containing a shared TNF homologous (TNFH) extracellular domain of approximately 150 amino acids which is responsible for trimer formation of these proteins (1) (2) . The TNFH regions can be proteolytically released as soluble trimeric proteins that, in many cases, are fully capable of interacting with their receptors. BAFF was identified as a TNF family member by searching the EST database for homology in amino acid sequence to the extracellular domain of TNF (3) (4) (5). The lack of peripheral B cells in BAFF null mice clearly demonstrated that BAFF is indispensable for maintaining the survival of peripheral B lymphocytes (6) . The extracellular domain of human BAFF was crystallized and shown to exist as a homotrimer (7) (8) (9) . The unusually long loop between the D and E b-strands that is present in each subunit of BAFF was reported to be responsible for assembly of 20 BAFF trimers into a virus-like cluster (7) . The functional significance of this loop was noted by the observation that the deletion of this loop in BAFF leads to loss of its activity to activate NFkB and to stimulate B cell proliferation (7) . Crystal structures of BAFF/receptor complexes revealed that the extracellular domain of BCMA or BAFF-R binds to the BAFF in a 3:3 molar ratio (10) (11).
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Among these receptors, BCMA and TACI also interact with APRIL (18) , a TNF ligand family member sharing significant sequence homology with BAFF (19) , while BAFF-R interacts exclusively with BAFF (17) . BCMA was initially identified as part of a translocation event in a T cell lymphoma (20) . The physiological role of BCMA is unclear since its distribution is primarily restricted to the Golgi apparatus in mature B cells (20) and the deficiency of this gene in mice has no apparent impact on B cells development (21) (22) . TACI, identified as the CAML-interacting protein (23) , is expressed in mature B cells and activated T cells. TACI has been implicated as a negative regulator for the homeostasis of B lymphocytes (24) (25) (26) . BAFF-R was identified via expression cloning for BAFF binding in the absence of BCMA and TACI and was shown to be expressed primarily on B cells (17) . The 3' end of this gene is disrupted in A/WySnJ mice, a strain that displays a B cell phenotype similar to BAFF-deficient mice which lack the majority of peripheral B cells (17) (25) . Hence BAFF-R is considered to be the principal receptor for BAFF-mediated B cell survival.
In contrast to most TNF receptor family members, whose extracellular domains usually contain several CRD modules, BCMA and BAFF-R have only one such module and TACI has only two. The extracellular domains of TNF receptors have been shown to be sufficient for interaction with their respective ligands. In fact, several soluble decoy receptors devoid of the transmembrane and cytoplasmic domains have been shown to be able to block the biological activity of the respective ligands (1) . The IgG 1 Fc fusion proteins of BCMA and TACI, BCMA-Fc and TACI-Fc, are capable of inhibiting B cell proliferation and antigen-specific antibody production (18) (27) (28) , presumably by blocking the activity of BAFF. This is consistent with the similar effect of BAFF-R-Fc in 7/34 were purchased from Sigma (St. Louis, MO). The peroxidase-and PE-conjugated antimouse, anti-human and anti-rabbit antibodies, F(ab') 2 goat-anti-mouse IgM, with and without streptavidin conjugated, were obtained from Jackson ImmunoResearch (West Grove, PA). Human IgG 1 was purchased from Protos ImmunoResearch (Burlingame, CA). Fluorescent probe BCECF (2',7'-bis(2-carboxyethyl-5(6)-carboxyfluorescein) was purchased from Molecular Probes (Eugene, OR). BCMA-Fc and BAFF-R-Fc were biotin-labeled at 1 mg/ml protein and 1 mg/ml EZ link sulfo-NHS-LC-biotin from Pierce (Rockland, IL) according to manufacturer's instructions. Biotin-labeled fusion proteins were tested for their ability to bind to BAFF in immunoprecipitation reactions and were found to have no loss in BAFF binding activity. The substrate for alkaline phosphatase, pNpp (p-nitrophenyl phosphate) was purchased from Sigma (St. Louis, MO).
ELISA of BAFF-R-Fc binding to FLAG-BAFF and FLAG-APRIL M2 was coated onto CoStar 96 well plates (#3369) at 5 mg /ml in 50 mM sodium bicarbonate buffer pH 9.6 overnight at 4˚C. The antibody solution was shaken out and the plate was blocked with 3 % BSA in PBS at room temperature for 30 minutes. The plate was washed with 0.05 % Tween 20 in PBS and FLAG-tagged BAFF and FLAGtagged APRIL were captured at 20 ng/ml for 1 hour at room temperature. The plate was washed, varying concentrations of BAFF-R-Fc were added in 3 % BSA in PBS and the plate was incubated at room temperature for 30 minutes. The plate was washed and bound BAFF-R-Fc was detected with anti-human Fc gamma alkaline phosphatase.
Positive signal was revealed with 5 mg/ml of pNpp in 10 % diethanolamine, 1 mM MgCl 2 , 1 mM ZnCl 2, pH 9.0 and the OD was determined at 405 nm. BCMA-Fc or BAFF-R-Fc was covalently derivatized onto Seize IP beads from Pierce (Rockford, IL) according to the manufacturer's instructions. The receptor-coated beads were mixed with varying concentrations of BCMA-Fc or BAFF-R-Fc, to which FLAG-BAFF was then added and rocked at 4˚C overnight followed by washing three times with 5 % FBS in PBS. These beads were then treated with Laemmli sample buffer, resolved by a SDS-PAGE under non-reducing conditions, followed by western blotting with M2 antibody and HRP-conjugated goat anti-mouse to detect FLAG-BAFF. After washing with 5 % FBS in PBS, beads were treated with Laemmli sample buffer and the biotin labeled receptor Fc protein was detected by HRP-conjugated streptavidin on a western blot. The detection of FLAG-BAFF was as described above.
ELISA of FLAG-BAFF binding to monovalent BAFF-R-Fc and BCMA-Fc ELISA was done similarly to the procedure outlined above. Anti-human IgG Fc antibody was coated onto ELISA plate. Monovalent BAFF-R-Fc and BCMA-Fc were captured at 2 mg/ml and varying concentrations of FLAG-BAFF were added and incubated at room temperature for 30 minutes. Bound FLAG-BAFF was detected with M2 antibody followed by anti-murine antibody conjugated with alkaline phosphatase. Unfortunately, we were unable to engineer and produce TACI-Fc fusion protein with similar homogeneity, which prevented us from including this decoy receptor in this study.
To determine if the introduction of the murine residues alters the biochemical properties of the BAFF-R, we tested its ability to interact with either BAFF or APRIL by ELISA. Figure 1A shows that the variant form of BAFF-R-Fc retains its ligand specificity by interacting with BAFF and not APRIL. We also investigated if BAFF binding affinity of the variant BAFF-R is different from that of wild-type BAFF-R. To minimize the potential avidity factor associated with ligand binding to surface expressed receptor that may mask differences in intrinsic affinity, we set up an assay in which the variant BAFF-R-Fc competed with surface expressed wildtype or variant BAFFR for BAFF binding. 
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These results show that the introduction of these two murine residues did not change the ligand specificity of this protein nor did it grossly alter the affinity of BAFF-R to interact with BAFF. For the sake of simplicity, we call this non-aggregated human variant BAFF-R Ig fusion protein BAFF-R-Fc.
BAFF-R-Fc disrupts BAFF/BCMA-Fc complexes, but BCMA-Fc has no effect on BAFF/BAFF-R-Fc complexes. A BAFF trimer forms stable complexes with more than one BAFF-R-Fc, but only one BCMA-Fc.
Since both ligand and receptors used in these tests are in the trimeric and dimeric forms, respectively, we considered a potential difference in the stoichiometry between these receptor-Fc proteins and BAFF that may lead to a difference in overall binding. Recent Xray crystal structure of the BAFF/BCMA and BAFF/BAFF-R complexes revealed that that one trimeric ligand is able to bind to three monovalent receptors (10) Crystal structure data showed that complexes of BAFF/BCMA and BAFF/BAFF-R exhibit 3:3 stoichiometry (10) (11). Thus, the observation that a trimeric BAFF can bind two BAFF-R-Fc but only one BCMA-Fc was puzzling until we realized that formation of stable BAFF/BCMA complexes requires that a divalent BCMA protein simultaneously occupies two of the three sites on a trimeric BAFF. In contrast, both monovalent and divalent BAFF-R are able to form a stable complex with BAFF.
Regarding the 3:3 stoichiometry in crystal of BAFF/BCMA complexes (10) (11), we reason that the concentration of BCMA within the crystal of receptor-ligand complexes is sufficient to stabilize the low affinity BAFF-BCMA interaction. It was also reported that BAFF interacts with surface-expressed BCMA with a nanomolar affinity (37) . Judging from our biochemical observations, this affinity measurement is likely reflecting multivalent interactions between the soluble trimeric BAFF and multiple BCMA molecules anchored on the cell surface, rather than a true monovalent interaction between a single BCMA molecule and a BAFF trimer.
Since BAFF interacts productively with the dimeric, but not monomeric, form of BCMA, it is possible that a functionally active form of BCMA has to assemble into dimers or 
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One important observation was that in the presence of BAFF-R, the interaction between BCMA and BAFF was undetectable as shown in Figure 4A , upper panel. This observation implies that while BCMA-Fc is able to decrease the effective concentrations of soluble BAFF in circulation, it is not capable of competing BAFF that was associated with BAFF-R. In contrast, BAFF-R is capable of competing BAFF --irrespective to whether the latter is free in circulation or bound to BAFF-R. Therefore, our results indicate that BCMA-Fc and BAFF-R-Fc both are effective for complexing with BAFF in circulation, but only BAFF-R-Fc is effective for competing BAFF bound to endogenous BAFF-R.
In contrast to the conventional TNFa-like trimeric structure, BAFF has been reported to assemble into a virus-like cluster consisting of 60 monomers (20 trimers) (10) . This is in contrast to our previous finding that the BAFF extracellular domain crystallizes into a homotrimer (8) . Our data shows that BAFF can stably bind to only one BCMA-Fc suggesting that the 60-mer form of BAFF is either very unstable in or is completely absent from our BAFF preparations. In fact, size exclusion chromatography of the BAFF used in experiments reported here revealed only one peak with an apparent molecular weight corresponding to a homotrimer (data not shown). It should also be noted that the BAFF protein used here was produced in a mammalian cell expression system (see Experimental Procedures). In contrast, the BAFF proteins forming 60-mer virus-like cluster were produced in either insect cell (10) or bacterial expression system (11). While the exact reason for different forms of BAFF is unclear, it is possible that difference in the expression systems may account for such a discrepancy. Receptor Fc (mg/ml) A Figure 6 by guest on January 21, 2018
